Drug interactions
Brexucabtagene autoleucel + Interferon beta 1b
Severity: Major
Brexucabtagene autoleucel and Interferon beta 1b: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Brexucabtagene autoleucel is a CAR-T therapy associated with prolonged cytopenias and infection susceptibility. Interferon beta may contribute additional immune effects and blood count suppression. Data on the combination are lacking.
What this interaction means in plain words
Brexucabtagene autoleucel and Interferon beta 1b can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Interferon beta 1b belongs to Central Nervous System.
Why it happens
Additive immunosuppressive and myelosuppressive effects; the effect on CAR-T expansion is not established.
What to do
Avoid interferon beta around CAR-T therapy and choose an alternative where possible. If coadministered, monitor blood counts and infection signs closely.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Interferon beta 1b, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Interferon beta 1b
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Interferon beta 1b?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Interferon beta 1b can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Brexucabtagene autoleucel is a CAR-T therapy associated with prolonged cytopenias and infection susceptibility. Interferon beta may contribute additional immune effects and blood count suppression. Data on the combination are lacking.
How serious is the interaction between Brexucabtagene autoleucel and Interferon beta 1b?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid interferon beta around CAR-T therapy and choose an alternative where possible. If coadministered, monitor blood counts and infection signs closely.
What other medicines interact with Interferon beta 1b?
MediHelp also lists interactions of Interferon beta 1b with, for example, Axicabtagene ciloleucel, Ciltacabtagene autoleucel, Deferiprone. The full list is on the Interferon beta 1b page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
